- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06869980
Efficacy of Limited Right Anterior Thoracotomy Versus Median Sternotomy for Mitral Valve Replacement
March 10, 2025 updated by: Zagazig University
this study compare between two diffrent methods for approach mitral valve in mitral valve replacement throgh opening of the middle of the sternum by saw or through opening between 4th and 5th rib on the right side of the chest without saw
Study Overview
Status
Completed
Conditions
Detailed Description
study the efficacy of mitral valve replacement by median sterntomy versus limited right thoractomy
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
El sharkia
-
Zagazig, El sharkia, Egypt
- Mohamed Samy Abdalla
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients diagnosed with acquired isolated mitral valve disease requiring mitral valve replacement > 18 years
Exclusion Criteria:
- patients with Previous cardiac surgery, • Patients less than 18 years, • Patients with other valvular heart lesions (aortic valve or tricuspid valve) , IHD Patients , Obese patients (BMI>35), COPD patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Limited Right Anterior Thoracotomy
mitral valve replacement through minimal invasive approach
|
The incision is placed just lateral to the nipple over the fourth intercostal space (above the nipple in men and in the inframammary crease in most women) 6-10 cm in length, the pectoralis muscles are mobilized for fourth intercostal space thoracic entry-The pericardium is opened 2-cm ventral to the phrenic nerve under direct vision and carried cephalad to the aortic reflection.
The anterior edge of the pericardium is tacked to incision edges using silk sutures-To initiate cardiopulmonary bypass, Cannulation of the femoral artery and femoral vein should be prior to mediastinal dissection-.
The ascending aorta occluded with an external clamp.
This aortic clamp passed through the thoracotomy incision if we use the aortic cross clamp and the anterograde cardioplegia delivered through a standard cardioplegia cannula secured with purse-string sutures in the ascending aorta.
|
|
Active Comparator: median sternotomy
mitral valve replacement through traditional median sterntomy approach
|
The incision is begun approximately 2 cm below the sternal notch and extended approximately 2 cm beyond the distal tip of the xiphoid process and is usually extended with the electrocautery down to the sternal periosteum.
A midline approach can be ensured by careful attention to the insertion points of the pectoralis major muscles onto the sternum; the incision should lie directly midway between these insertion points.After sternotomy, the pericardium is opened; the heart is cannulated for cardiopulmonary bypass.
Arterial inflow is established by cannulation of the distal ascending aorta near the pericardial reflection.
Double venous cannulation of the venae cavae by way of the right atrium is generally employed.
In most adults a size 32 Fr cannula in the superior vena cava and a size 34-38 Fr cannula in the inferior vena cava provide excellent venous drainage and easy fit.
Encircling of the venae cavae and their generous mobilization aid in the subsequent exposure of the mitral valve.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
length of skin incision (cosmotic scar)
Time Frame: 1 week after surgery
|
measured by centimetre by ruler
|
1 week after surgery
|
|
post operative pain threshold (Visual analog scale (VAS):0 to 10 assess pain from no pain-mild -moderate- sever-worst pain possible
Time Frame: 5 days after surgery
|
measured by universal pain assessment tool
|
5 days after surgery
|
|
wound satisfaction scale (quality of life questionnaire)
Time Frame: 2 weeks after surgery
|
modified Likert scale for wond satisfaction:(very dissatisfied,dissatisfied,neutral, satisfied,very satisfied)
|
2 weeks after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohamed Sa Abdalla, lecturer, cardiothoracic surgery department-faculty of medecine-Zagazig univeristy-Egypt
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2022
Primary Completion (Actual)
May 20, 2023
Study Completion (Actual)
September 15, 2023
Study Registration Dates
First Submitted
February 25, 2025
First Submitted That Met QC Criteria
March 10, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 10, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- ZU-IRB # 9413-13-4-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Minimal Invasive Cardiac Surgery
-
Universitätsklinikum Hamburg-EppendorfCompletedSerratus Anterior Plane Block | Minimal Invasive Cardiac Surgery | Minimal Invasive Cardiac Surgery Mitral Valve SurgeryGermany
-
Algemeen Ziekenhuis Maria MiddelaresCompletedAortic Valve Replacement | Mitral Valve Surgery | Minimal Invasive Cardiac Surgery | Minimal Invasive Direct Coronary Artery BypassBelgium
-
Hospital Son LlatzerFundació d'investigació Sanitària de les Illes BalearsActive, not recruitingHemorrhoidectomy | Minimal Invasive SurgerySpain
-
Koç UniversityRecruitingMinimal Invasive Heart Surgery | Rhomboid Intercostal Nerve BlockTurkey
-
Ankara City Hospital BilkentCompletedAcute Pain | Serratus Anterior Plane Block | Postoperative Analgesia | Minimal Invasive Cardiac SurgeryTurkey
-
Ankara City Hospital BilkentCompletedPostoperative Pain | Minimal Invasive Cardiac SurgeryTurkey
-
Queen Savang Vadhana Memorial Hospital, ThailandRecruitingHallux Valgus | Minimal Invasive Surgery | Hallux Valgus Deformity | Hallux Valgus CorrectionThailand
-
Karolinska University HospitalRecruitingMinimally Invasive Cardiac SurgerySweden
-
Pusan National University Yangsan HospitalCompletedMinimally Invasive Cardiac SurgeryKorea, Republic of
-
Shanghai Zhongshan HospitalUnknownMinimally Invasive Cardiac Surgery
Clinical Trials on mitral valve replacement through limited right anterior thoractomy
-
Sohag UniversityNot yet recruitingMinimally Invasive Mitral Valve SurgeryEgypt
-
Jena University HospitalThe German Heart FoundationUnknownAortic Valve StenosisGermany